GEODE CAPITAL MANAGEMENT, LLC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,074,000
+190.3%
832,898
+136.2%
0.00%
Q3 2019$370,000
-38.5%
352,585
-0.6%
0.00%
Q2 2019$602,000
-65.6%
354,660
-31.6%
0.00%
Q1 2019$1,748,000
-41.2%
518,714
-49.1%
0.00%
Q4 2018$2,974,000
+13.7%
1,018,620
+139.8%
0.00%
-100.0%
Q3 2018$2,616,000
-11.4%
424,793
+6.1%
0.00%0.0%
Q2 2018$2,953,000
+97.9%
400,232
+75.9%
0.00%
Q1 2018$1,492,000
-20.9%
227,502
+1.4%
0.00%
-100.0%
Q4 2017$1,887,000
-26.1%
224,418
+1.4%
0.00%0.0%
Q3 2017$2,555,000
+8.4%
221,273
+9.6%
0.00%0.0%
Q2 2017$2,357,000
+6.7%
201,801
+12.7%
0.00%0.0%
Q1 2017$2,209,000
+6.9%
179,012
+17.9%
0.00%0.0%
Q4 2016$2,067,000
-36.9%
151,811
-7.8%
0.00%
-50.0%
Q3 2016$3,276,000
+211.4%
164,638
+102.8%
0.00%
+100.0%
Q2 2016$1,052,000
+74.2%
81,189
+25.6%
0.00%
Q1 2016$604,000
-52.0%
64,665
+4.0%
0.00%
-100.0%
Q4 2015$1,259,000
+38.2%
62,152
-0.9%
0.00%0.0%
Q3 2015$911,000
-43.1%
62,698
-16.7%
0.00%0.0%
Q2 2015$1,601,000
-7.2%
75,286
+1.0%
0.00%0.0%
Q1 2015$1,726,00074,5090.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,051,441$3,070,0000.79%
X-Square Capital, LLC 109,832$321,0000.25%
KNOTT DAVID M 111,427$325,0000.15%
ARK Investment Management 1,033,491$3,018,0000.12%
Baker Brothers Advisors 2,677,818$7,819,0000.06%
HARVEY CAPITAL MANAGEMENT INC 31,200$91,0000.05%
DAFNA Capital Management LLC 30,000$88,0000.04%
WASATCH ADVISORS LP 953,368$2,784,0000.04%
FRANKLIN STREET ADVISORS INC /NC 51,415$150,0000.02%
FARALLON CAPITAL MANAGEMENT LLC 1,000,000$2,920,0000.02%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders